FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060521796> ?p ?o ?g. }

• W2060521796 endingPage "1113" @default.
• W2060521796 startingPage "1111" @default.
• W2060521796 abstract "Levels of circulating cell adhesion molecules (cCAM) may be useful markers for stratifying cardiovascular disease severity or prognosis. 1 Blann A.D Lip G.Y.H Cell adhesion molecules in cardiovascular disease and its risk factors—what can soluble levels tell us?. J Clin Endocrinol Metab. 2000; 85: 1745-1747 Crossref PubMed Scopus (46) Google Scholar , 2 Oishi Y Wakatsuki T Nishikado A Oki T Ito S Circulating adhesion molecules and severity of coronary atherosclerosis. Coronary Artery Dis. 2000; 11: 77-81 Crossref PubMed Scopus (64) Google Scholar , 3 Hwang S.J Ballantyne C.M Sharrett A.R Smith L.C Davis C.E Gotto A.M Boerewinkle E Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in atherosclerosis and incident coronary heart disease cases. Circulation. 1997; 96: 4219-4225 Crossref PubMed Scopus (1236) Google Scholar , 4 Peter K Nawrot P Conradt C Nordt T Weiss T Boehme M Wunsch A Allenberg J Kübler W Bode C Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol. 1997; 17: 505-512 Crossref PubMed Scopus (278) Google Scholar Furthermore, cCAM levels are elevated in subjects with insulin resistance, type 2 diabetic patients, hypertensive patients, and in smokers. 5 Chen N-G Holmes M Reaven G.M Relationship between insulin resistance, soluble adhesion molecules, and mononuclear cell binding in healthy volunteers. J Clin Endocrinol Metab. 1999; 84: 3485-3489 Crossref PubMed Scopus (103) Google Scholar , 6 Jilma B Dallinger S Hergovich N Eichler H.G Richter V Wagner O.F Effects of hyperinsulinemia on plasma levels of circulating adhesion molecules. J Clin Endocrinol Metab. 2000; 85: 1748-1751 Crossref PubMed Scopus (28) Google Scholar , 7 Cominacini L Pasini A.F Garbin U Campagnola M Davoli A Rigoni A Zenti M.G Pastorino A.M Cascio V.L E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients possible role of oxidative stress. Diabetologia. 1997; 40: 584-589 Crossref PubMed Scopus (98) Google Scholar , 8 Wagner O.F Jilma B Putative role of adhesion molecules in metabolic disorders. Horm Metab Res. 1997; 29: 627-630 Crossref PubMed Scopus (35) Google Scholar , 9 Ferri C Desideri G Baldoncini R Bellini C De Angelis C Mazzocchi C Santucci A Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes. 1998; 47: 660-667 Crossref PubMed Scopus (133) Google Scholar , 10 Richter V Wagner O.F Rassoul F Circulating cell adhesion molecules in patients with risk factors for atherosclerosis. Atherosclerosis. 1999; 144: 56 Abstract Full Text PDF Google Scholar , 11 Price D.T Loscalzo J Cellular adhesion molecules and atherogenesis. Am J Med. 1999; 107: 85-97 Abstract Full Text Full Text PDF PubMed Scopus (357) Google Scholar The reported effects of hypercholesterolemia on cCAM levels, however, has been controversial. 12 Sampietro T Tuoni M Ferdeghini M Ciardi A Marraccini P Protera C Sassi G Taddei M Bionda A Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation. 1997; 96: 1381-1385 Crossref PubMed Scopus (99) Google Scholar , 13 Morisaki N Saito I Tamura K Tashiro J Masuda M Kanzaki T Watanabe S Masuda Y Saito Y New indices of ischemic heart disease and aging studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis. 1997; 131: 43-48 Abstract Full Text Full Text PDF PubMed Scopus (123) Google Scholar , 14 Hackman A Abe Y Insull W Pownall H Smith L Dunn K Gotto A.M Ballantyne C.M Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation. 1996; 93: 1334-1338 Crossref PubMed Scopus (309) Google Scholar , 15 Paiker J.E Raal F.J Veller M von Arb M Chetty N Naran N.H Cell adhesion molecules—can they be used to predict coronary artery disease in patients with familial hypercholesterolaemia?. Clin Chim Acta. 2000; 293: 105-113 Crossref PubMed Scopus (22) Google Scholar Sampietro and colleagues 12 Sampietro T Tuoni M Ferdeghini M Ciardi A Marraccini P Protera C Sassi G Taddei M Bionda A Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation. 1997; 96: 1381-1385 Crossref PubMed Scopus (99) Google Scholar reported that familial hypercholesterolemia was associated with elevated levels of cICAM-1 and cE-selectin. They found a decrease in the levels of these soluble CAMs immediately after extracorporeal low-density lipoprotein (LDL) elimination, which is capable of preventing the progression and initiating the regression of atherosclerosis in hypercholesterolemic patients by inducing functional improvement, which may precede anatomic changes. 16 Mabuchi H Koizumi J Shimizu M Kajinami K Miyamoto S Ueda K Takegoshi T Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholestrolemia. Am J Cardiol. 1998; 82: 1489-1495 Abstract Full Text Full Text PDF PubMed Scopus (255) Google Scholar , 17 Mellwig K-P Baller D Gleichmann U Moll D Betker S Weise R Notohamiprodjo G Improvement of coronary vasodilatation capacity through single LDL apheresis. Atherosclerosis. 1998; 139: 173-178 Abstract Full Text Full Text PDF PubMed Scopus (112) Google Scholar According to their hypothesis, plasma cholesterol regulates soluble CAM expression in familial hypercholesterolemia and soluble CAMs may serve as markers of efficacy in lipid-lowering trials. Futhermore, they concluded that the beneficial effects of LDL elimination on cardiovascular risk may be partially attributable to the downregulation of endothelial CAMs. 12 Sampietro T Tuoni M Ferdeghini M Ciardi A Marraccini P Protera C Sassi G Taddei M Bionda A Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation. 1997; 96: 1381-1385 Crossref PubMed Scopus (99) Google Scholar Such an effect, if at least partially mediated by downregulation of endothelial CAM expression, would, however, presume a long-term effect. In contrast, a number of studies have shown that hypercholesterolemia is not correlated with increased cCAM levels. 13 Morisaki N Saito I Tamura K Tashiro J Masuda M Kanzaki T Watanabe S Masuda Y Saito Y New indices of ischemic heart disease and aging studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis. 1997; 131: 43-48 Abstract Full Text Full Text PDF PubMed Scopus (123) Google Scholar , 15 Paiker J.E Raal F.J Veller M von Arb M Chetty N Naran N.H Cell adhesion molecules—can they be used to predict coronary artery disease in patients with familial hypercholesterolaemia?. Clin Chim Acta. 2000; 293: 105-113 Crossref PubMed Scopus (22) Google Scholar Therefore, the aim of the present study was to assess both the short- and long-term effects of LDL apheresis on the levels of circulating intercellular cell adhesion molecule (cICAM-1), circulating vascular cell adhesion molecule (cVCAM-1), and cE-selectin in patients with familial hypercholesterolemia." @default.
• W2060521796 created "2016-06-24" @default.
• W2060521796 creator A5002027109 @default.
• W2060521796 creator A5013130062 @default.
• W2060521796 creator A5023041695 @default.
• W2060521796 creator A5025318862 @default.
• W2060521796 creator A5028478397 @default.
• W2060521796 creator A5061428818 @default.
• W2060521796 creator A5066874948 @default.
• W2060521796 creator A5082163795 @default.
• W2060521796 date "2001-05-01" @default.
• W2060521796 modified "2023-10-18" @default.
• W2060521796 title "Effect of extracorporeal low-density lipoprotein elimination on circulating cell adhesion molecules in patients with hypercholesterolemia" @default.
• W2060521796 cites W1972919038 @default.
• W2060521796 cites W1976778785 @default.
• W2060521796 cites W1984829261 @default.
• W2060521796 cites W1986322454 @default.
• W2060521796 cites W2002565780 @default.
• W2060521796 cites W2008009125 @default.
• W2060521796 cites W2008501517 @default.
• W2060521796 cites W2021536249 @default.
• W2060521796 cites W2025221620 @default.
• W2060521796 cites W2031638575 @default.
• W2060521796 cites W2046750893 @default.
• W2060521796 cites W2049836623 @default.
• W2060521796 cites W2069861938 @default.
• W2060521796 cites W2072643235 @default.
• W2060521796 cites W2079152120 @default.
• W2060521796 cites W2088471254 @default.
• W2060521796 cites W2325043984 @default.
• W2060521796 doi "https://doi.org/10.1016/s0002-9149(01)01473-4" @default.
• W2060521796 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11348614" @default.
• W2060521796 hasPublicationYear "2001" @default.
• W2060521796 type Work @default.
• W2060521796 sameAs 2060521796 @default.
• W2060521796 citedByCount "13" @default.
• W2060521796 countsByYear W20605217962017 @default.
• W2060521796 crossrefType "journal-article" @default.
• W2060521796 hasAuthorship W2060521796A5002027109 @default.
• W2060521796 hasAuthorship W2060521796A5013130062 @default.
• W2060521796 hasAuthorship W2060521796A5023041695 @default.
• W2060521796 hasAuthorship W2060521796A5025318862 @default.
• W2060521796 hasAuthorship W2060521796A5028478397 @default.
• W2060521796 hasAuthorship W2060521796A5061428818 @default.
• W2060521796 hasAuthorship W2060521796A5066874948 @default.
• W2060521796 hasAuthorship W2060521796A5082163795 @default.
• W2060521796 hasConcept C126322002 @default.
• W2060521796 hasConcept C16224149 @default.
• W2060521796 hasConcept C164705383 @default.
• W2060521796 hasConcept C203014093 @default.
• W2060521796 hasConcept C2776104379 @default.
• W2060521796 hasConcept C2778163477 @default.
• W2060521796 hasConcept C2779120738 @default.
• W2060521796 hasConcept C2779620165 @default.
• W2060521796 hasConcept C2779915274 @default.
• W2060521796 hasConcept C2780072125 @default.
• W2060521796 hasConcept C2994232697 @default.
• W2060521796 hasConcept C71924100 @default.
• W2060521796 hasConceptScore W2060521796C126322002 @default.
• W2060521796 hasConceptScore W2060521796C16224149 @default.
• W2060521796 hasConceptScore W2060521796C164705383 @default.
• W2060521796 hasConceptScore W2060521796C203014093 @default.
• W2060521796 hasConceptScore W2060521796C2776104379 @default.
• W2060521796 hasConceptScore W2060521796C2778163477 @default.
• W2060521796 hasConceptScore W2060521796C2779120738 @default.
• W2060521796 hasConceptScore W2060521796C2779620165 @default.
• W2060521796 hasConceptScore W2060521796C2779915274 @default.
• W2060521796 hasConceptScore W2060521796C2780072125 @default.
• W2060521796 hasConceptScore W2060521796C2994232697 @default.
• W2060521796 hasConceptScore W2060521796C71924100 @default.
• W2060521796 hasIssue "9" @default.
• W2060521796 hasLocation W20605217961 @default.
• W2060521796 hasLocation W20605217962 @default.
• W2060521796 hasOpenAccess W2060521796 @default.
• W2060521796 hasPrimaryLocation W20605217961 @default.
• W2060521796 hasRelatedWork W1985099812 @default.
• W2060521796 hasRelatedWork W1989842691 @default.
• W2060521796 hasRelatedWork W2010852640 @default.
• W2060521796 hasRelatedWork W2027406869 @default.
• W2060521796 hasRelatedWork W2081157663 @default.
• W2060521796 hasRelatedWork W2083231110 @default.
• W2060521796 hasRelatedWork W2083338582 @default.
• W2060521796 hasRelatedWork W2091410379 @default.
• W2060521796 hasRelatedWork W2159236706 @default.
• W2060521796 hasRelatedWork W2016060162 @default.
• W2060521796 hasVolume "87" @default.
• W2060521796 isParatext "false" @default.
• W2060521796 isRetracted "false" @default.
• W2060521796 magId "2060521796" @default.
• W2060521796 workType "article" @default.